Supplements
Kirin and FANCL debut AI platform to optimize supplement tablet formulations
29 Jul 2026 | By Benjamin Ferrer
Key takeaways
Kirin and FANCL developed an AI platform that evaluates thousands of formulation combinations to optimize supplement tablet size, hardness, and ease of swallowing.
The system replaces manual trial-and-error with automated predictions, accelerating development timelines while reducing raw material loss.
Kirin plans to leverage its R&D data to expand the scope of AI applications across future nutraceutical innovations.
Kirin Holdings Company and FANCL Corporati
原文链接：https://www.nutritioninsight.com/news/kirin-fancl-ai-supplements-tablet-formulation.html